ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

TMA Development in Kidney and Heart Xenografts Treated with Anti-CD40 or Anti-CD154 Antibodies

D. H. Ma1, H. Sasaki1, J. M. O1, K. Ahrens1, D. Becerra1, C. G. Rickert1, D. M. Detelich1, T. Oura1, W. Somer1, I. Rosales2, R. N. Pierson1, J. Markmann1, J. C. Madsen1, T. Kawai1

1Surgery, MGH, Boston, MA, 2Pathology, MGH, Boston, MA

Meeting: 2019 American Transplant Congress

Abstract number: D74

Keywords: Heart, Kidney transplantation, Pig, Primates

Session Information

Session Name: Poster Session D: Xenotransplantation

Session Type: Poster Session

Date: Tuesday, June 4, 2019

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall C & D

*Purpose: Genetically modified Galactose-α 1,3-galactose knockout transgenic swine expressing human CD55 (GTKO.hCD55) are resistant to hyperacute rejection of xenografts. We compare anti-CD154 and anti-CD40 antibody-based regimens in kidney and heart xenotransplant models.

*Methods: Cynomologus macaque recipients of GTKO.hCD55 pig kidneys (4) or hearts (3) were treated with rabbit ATG and anti-CD20 mAb as induction, followed by daily MMF, methylprednisolone and sirolimus, as well as weekly anti-CD40 (2C10R4, 20 mg/kg) or anti-CD154 (hu5c8, 20 mg/kg) antibody. In kidney transplantation, 2 recipients received anti-CD40 and the other 2 received anti-CD154. All 3 heart recipients received anti-CD40.

*Results: Kidney recipients receiving the anti-CD40 regimen lost graft function on days 11 and 15 in association with thrombotic microangiopathy (TMA) with mild rejection in one recipient. In contrast, both kidney recipients with anti-CD154 regimen exhibited preserved kidney function until euthanized on days 76 and 93 due to weight loss. Moderate TMA and evidence of chronic rejection was present in one and only C4d deposition in the other. Unlike kidney recipients, heart recipients treated with anti-CD40 did not exhibit TMA, and recipients were euthanized due to acute rejection (d 80) or intractable anemia (d 30, 65), with severe AMR in one.

*Conclusions: Our initial experience suggests that GTKO.hCD55 kidney xenotransplant recipients, exhibit rapid onset of TMA with anti-CD40 regimen, which was effectively inhibited by anti-CD154. In contrast, TMA was not observed in heart xenografts, demonstrating organ-specific susceptibility to TMA.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Ma DH, Sasaki H, O JM, Ahrens K, Becerra D, Rickert CG, Detelich DM, Oura T, Somer W, Rosales I, Pierson RN, Markmann J, Madsen JC, Kawai T. TMA Development in Kidney and Heart Xenografts Treated with Anti-CD40 or Anti-CD154 Antibodies [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/tma-development-in-kidney-and-heart-xenografts-treated-with-anti-cd40-or-anti-cd154-antibodies/. Accessed May 8, 2025.

« Back to 2019 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences